Home/Filings/8-K/0001169245-23-000050
8-K//Current report

PhaseBio Pharmaceuticals Inc 8-K

Accession 0001169245-23-000050

CIK 0001169245operating

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 8:52 AM ET

Size

4.5 MB

Accession

0001169245-23-000050